The Gerson group reported that a short-hairpin RNA (shRNA) targeting human UNG led to sensitization of p53-mutant cancer cells to FdU (5), and that depletion of UNG in a mouse xenograft model of lung cancer reduced tumor growth in combination with pemetrexed treatment (10). Here, UNG is linked to neoplasm.